These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4357679

  • 41. Adrenocortical suppression with small doses of topical corticosteroids.
    Carr RD, Belcher RW.
    Acta Derm Venereol; 1969; 49(5):508-13. PubMed ID: 4186337
    [No Abstract] [Full Text] [Related]

  • 42. Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis.
    Lam CN, Arneil GC.
    Arch Dis Child; 1968 Oct; 43(231):589-94. PubMed ID: 4301384
    [No Abstract] [Full Text] [Related]

  • 43. [Excretion of free 11-hydroxycorticosteroids in newborns and in childhood before and after ACTH administration].
    Hubl W, Lehmann GW.
    Acta Paediatr Acad Sci Hung; 1970 Oct; 11(2):115-20. PubMed ID: 4323420
    [No Abstract] [Full Text] [Related]

  • 44. Microscopic nephrocalcinosis and hypercalciuria in nephrotic syndrome.
    Mocan H, Yildiran A, Camlibel T, Kuzey GM.
    Hum Pathol; 2000 Nov; 31(11):1363-7. PubMed ID: 11112210
    [Abstract] [Full Text] [Related]

  • 45. [Stimulation of adrenal cortex function during corticosteroid therapy by the method of variable hormonal vacuum].
    Oleĭnik SF, Zaremba EF.
    Vrach Delo; 1969 Aug; 8():22-6. PubMed ID: 5199455
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Prognosis of the idiopathic nephrotic syndrome in children].
    Hooft C, van Acker KJ.
    Verh K Vlaam Acad Geneeskd Belg; 1974 Aug; 36(2):74-105. PubMed ID: 4365634
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B, Roux H, Audi-Parera L, David M, Bertrand J.
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Hypothalamic-pituitary-adrenal (HPA) function in adrenocortical steroid treated minimal change nephrotic syndrome.
    Moel DI, Kwun YA, Teitcher J.
    Clin Nephrol; 1980 Jul; 14(1):36-41. PubMed ID: 6250751
    [Abstract] [Full Text] [Related]

  • 54. [Nephrotic syndrome in childhood].
    Joppich R.
    Med Klin; 1974 Jan 25; 69(4):128-34. PubMed ID: 4592292
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Studies on adrenocortical suppression due to steroid therapy in children. 2. Adrenocortical suppression during administration of adrenal cortex hormone preparations].
    TAKAKURA I.
    Paediatr Jpn; 1962 Nov 01; 66():750-6. PubMed ID: 13984570
    [No Abstract] [Full Text] [Related]

  • 57. [Therapy of the nephrotic syndrome in children].
    Linneweh F.
    Minerva Med; 1973 Oct 27; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.